Regarding sex differences, women show higher AD prevalence,(Gustavsson et al., 2023) faster accumulation of cortical tau as measured with PET(Wisch et al., 2021) and greater cortical atrophy(Sauty and Durrleman, 2023) compared to males in clinical stages. This evidence concerns the gene MAPT and Alzheimer disease.